Clinical trial
Comparable Effects of Lanreotide Autogel and Octreotide LAR on GH, IGF-I Levels and Patient Satisfaction - A Twelve Month Randomized Cross-Over Study in Patients With Acromegaly
NCT00145405 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparable Effects of Lanreotide Autogel and Octreotide LAR on GH, IGF-I Levels and Patient Satisfaction - A Twelve Month Randomized Cross-Over Study in Patients With Acromegaly
- Lead sponsor
- Odense University Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2002
- Completion date
- December 31, 2004
- Enrollment
- 12
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.